Methyl Indole-4-Carboxylate CAS 39830-66-5 Purity > 98.0% (HPLC) Hoobkas High Quality Featured duab

Methyl Indole-4-Carboxylate CAS 39830-66-5 Purity > 98.0% (HPLC) Hoobkas Zoo

Lus piav qhia luv luv:

Lub npe tshuaj: Methyl Indole-4-Carboxylate

CAS: 39830-66-5 Nr

Purity:> 98.0% (HPLC)

Pleev daj rau daj ntseg liab liab daj siv lead ua los yog hmoov

High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com

Xa email rau peb

Product Detail

Yam khoom

Khoom cim npe

Nqe lus piav qhia:

Shanghai Ruifu Chemical Co., Ltd. yog cov chaw tsim khoom thiab cov chaw muag khoom ntawm Methyl Indole-4-Carboxylate (CAS: 39830-66-5) nrog cov khoom zoo, kev lag luam ntau lawm.Txais tos kom xaj.

Chemical Properties:

Tshuaj npe	Methyl Indole-4-Carboxylate
Synonyms	Methyl 4-Indolecarboxylate;Indole-4-Carboxylic Acid Methyl Ester
CAS Nr	39830-66-5
CAT Number	Qauv TSIS MUAJ: RF-PI1555
Tshuag xwm txheej	Nyob rau hauv Tshuag, ntau lawm Scale mus txog Tons
Molecular Formula	C10H9NO2
Molecular Luj	175.19 Nws
Solubility	Soluble hauv Methanol
Hom	Ruifu Tshuaj

Specifications:

Yam khoom	Specifications
Qhov tshwm sim	Pleev daj rau daj ntseg liab liab daj siv lead ua los yog hmoov
1 H NMR Spectrum	Raws li tus qauv
Purity / Analysis Method	> 98.0% (HPLC)
Melting Point	68.0 ~ 71.0 ℃ (lit.)
Poob rau ziab	<1.00%
Residue ntawm Ignition	<0.20%
Tag nrho cov impurities	<2.00%
Test Standard	Enterprise Standard
Kev siv	Pharmaceutical Intermediates

Pob & Cia:

Pob: Lub raj mis, Aluminium ntawv ci hnab, 25kg / Cardboard Nruas, los yog raws li tus neeg yuav tsum tau muaj.

Cia txias:Khaws rau hauv cov thawv ntim khoom ntawm qhov chaw txias thiab qhuav;Tiv thaiv los ntawm lub teeb thiab noo noo.

Qhov zoo:

FAQ:

Daim ntawv thov:

Methyl Indole-4-Carboxylate (CAS: 39830-66-5),Reactant rau kev npaj ntawm tryptophan dioxygenase inhibitors pyridyl-ethenyl-indoles raws li muaj peev xwm anticancer immunomodulators;Reactant rau kev npaj cov tshuaj cytotoxic tiv thaiv kab mob qog noj ntshav multidrug-resistant;Reactant rau kev npaj ntawm inhibitor rau β-tryptase;Reactant rau kev npaj ntawm histamine H3 antagonists;Reactant rau kev npaj ntawm JNK3 MAP kinase inhibitors;Reactant rau kev npaj ntawm nucleosides.